---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-119532"
form_type: "8-K"
ticker: "GANX"
cik: "0001819411"
company_name: "Gain Therapeutics, Inc."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-08T00:20:48.719351+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Gain Therapeutics terminates at-the-market offering agreement with Cantor Fitzgerald

## Summary
- Terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective Nov 13, 2023.
- Agreement allowed for at-the-market sales; 865,535 shares sold for net proceeds of $3.5M total.
- Company gave immediate notice; no reason for termination provided in the filing.

## SEC filing metadata
- accession: 0001104659-23-119532
- form_type: 8-K
- ticker: GANX
- cik: 0001819411
- company_name: Gain Therapeutics, Inc.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/0001104659-23-119532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/tm2330139d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-119532
- JSON: https://secwatch.observer/filing/0001104659-23-119532.json
- Plain text: https://secwatch.observer/filing/0001104659-23-119532.txt

## Key facts
- Material Agreements
  Gain Therapeutics, Inc. terminated Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-11-13).
  - Action: termination
  - Agreement: atm program
  - Counterparty: Cantor Fitzgerald & Co.
  - Effective: 2023-11-13
  source text: On November 13, 2023, Gain Therapeutics, Inc. (the “ Company ”) notified Cantor Fitzgerald & Co. (“ Cantor ”) of its decision to terminate the Controlled Equity Offering SM Sales Agreement, dated as of May 18, 2022, (the “ Sales Agreement ”) between the Company and Cantor, effective immediately (the “ Termination Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/0001104659-23-119532-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.